The purpose of this research is to learn whether the investigational study drug BMS-986504 works to treat metastatic (cancer that has spread in the body) pancreatic ductal adenocarcinoma (PDAC) when combined with standard chemotherapy in participants with homozygous MTAP deletion or MTAP loss, who have not previously received treatment for metastatic PDAC.

We're looking at two alcohol sensors you can wear, the BACtrack Skyn and ArborSense. We want to know how easy and comfortable these are for you to use every day. Your feedback will help us decide which device is better for future studies.

This study is being conducted to see how well a study drug called ponsegromab works and if it might improve health and quality of life compared to a placebo in adults who have cachexia (a condition causing significant unintentional weight loss and muscle wasting) and metastatic pancreatic cancer, for which they receive initial chemotherapy.

Are you a Korean speaker living in the U.S. who has used a medical interpreter in a hospital? We are conducting a study to learn about your communication experiences with interpreters and healthcare providers. You can choose to complete a short online survey or participate in a one-on-one interview in Korean. You may enter a drawing based on chance in which each participant has equal odds of receiving the incentive for the survey and receive a gift card for participating in the interview. The study has been modified to broaden the survey participant criteria to include individuals who have not used medical interpreter services, in addition to those who have.

We're doing this study to understand how a type of genetic material called DNA in the blood changes in people with a specific type of cancer that has spread to only a few places in the body. By looking at how this DNA behaves before and after cancer treatment, including radiation, we aim to learn more about how the cancer responds. To do this, we'll collect blood and tumor samples from you to analyze what's happening. This could help in better understanding and improving cancer treatments for others in the future.

Have you been diagnosed with Leukemia? Do you have a functioning kidney, liver, and cardiac organ? If so, you may be able to participate in a study on a new drug called Ziftomenib. We want to find out if it hooking their interest enough to click on the link to is safe for people with Leukemia. Compensation provided.

Are you feeling a lack of interest in your hobbies, overwhelmed, or disconnected? If you are EITHER experiencing regular menstrual cycles OR more than a year from your last menstrual period, you may be able to participate in a research study to better understand the brain across the menopause transition. Compensation provided.

Do you have epilepsy and wish that exercise programs actually fit your needs? If you are diagnosed with epilepsy, are 18 years or older, and live in the United States, you may be able to participate in a research study by completing a brief, anonymous online survey about your exercise preferences and what helps or makes it harder to stay active as a person with epilepsy. You could also enter a drawing to win one of five, $50 Amazon gift cards with an equal probability of winning.

Are you tired of answering the usual questions about things like gender, race, and income on surveys? We need your help! We want to make these questions better to understand everyone's health needs in the U.S. Participating is easy and helps improve the way we ask these important questions. Interested? Join us today!

We are currently recruiting for a new clinical trial investigating the feasibility of five days of personalized non-invasive brain stimulation for antenatal depression. In the first Phase of this study, we investigated this in healthy controls, and in the current phase, we are investigating this intervention in people with antenatal depression (depression during pregnancy). You will be compensated up to $600 for participation in the study, which includes a virtual screening, a baseline visit to measure high-density electroencephalography (HD-EEG), 5 consecutive in-person visits with stimulation over one week, one virtual follow up 2 weeks after the study, and a final virtual follow up 4-6 weeks after birth. We will then check your medical chart within 90 days of birth to review birth outcomes. If you are interested in participating in this study, you can fill out our pre-screening form to help us determine if you may be eligible.